Emory's Ticiana Leal, MD, Says Rise in Druggable Targets Boosts Importance of Biomarker Testing in NSCLC

Coverage from the Institute for Value-Based Medicine event in Atlanta, held in partnership with Winship Cancer Institute of Emory University.

Related Keywords

United States ,American , ,Emory Winship Cancer Institute ,National Comprehensive Cancer Network ,Flatiron Health ,Department Of Hematology ,Emory University Ticiana Leal ,American Society Of Clinical Oncology ,Winship Cancer Institute ,Institute For Value ,Emory University ,Ticiana Leal ,Medical Oncology ,Thoracic Medical Oncology ,American Journal ,Managed Care ,Winship Cancer ,American Society ,Clinical Oncology ,Memory ,Nsclc ,Ivbm ,Tissue Based Testing ,Liquid Biopsy ,Biomarker Testing ,